US Archives - Page 3 of 198 - European Medical Journal

Older adult discussing metastatic NSCLC treatment options with an oncology clinician.

Metastatic NSCLC Treatment Remains Low in Older Adults

Metastatic NSCLC treatment remains underused among older adults, despite major therapeutic advances over 15 years.

Diarrhea Management in HER2-Mutant NSCLC

Oncology nurses support patients receiving targeted therapy by educating them on adverse event management. This infographic summarizes…

https://chatgpt.com/c/6a0f7ba2-cca4-83ea-b72f-b314c3deef67#:~:text=Person%20holding%20a%20warm%20drink%20to%20represent%20taste%20and%20smell%20dysfunction%20after%20immune%20checkpoint%20inhibitor%20therapy.

Taste and Smell Largely Preserved After Immunotherapy

Immune checkpoint inhibitor therapy rarely caused persistent taste and smell dysfunction in long term survivors after cancer treatment.

AI retinal imaging for Alzheimer’s disease detection in an older adult eye examination

AI Retinal Imaging Targets Earlier Alzheimer’s Detection

AI retinal imaging could help identify adults needing Alzheimer’s disease referral in primary care settings.

Hospital laboratory surveillance for antimicrobial resistance and infection outcomes in hospitalized patients.

Certain Hospital Infections Show Markedly Lower Survival

Antimicrobial resistance surveillance identified infection-specific survival patterns across 7,434 hospitalized patients treated in five countries.

Clinicians reviewing lung imaging in a discussion about nontuberculous mycobacterial lung disease.

Airway Inflammation Linked to Mycobacterial Lung Disease

Nontuberculous mycobacterial lung disease may be shaped by airway inflammation, disease severity, and infection duration.

Dermatology consultation for genital discoid lupus and chronic inflammatory skin disease diagnosis.

Chronic Rash May Signal Rare Lupus

Genital discoid lupus may mimic common inflammatory dermatoses, making biopsy critical in chronic genital rashes.

Interview with Maciej M. Mrugala

While in medical school in Warsaw, I was involved in basic science research from my second year. I was very interested in biochemistry…

ATS 2026: Ralinepag Trial Targets PAH Disease Progression

Ralinepag may offer once daily prostacyclin pathway targeting for PAH patients already receiving background therapy.

Clinician reviewing digital gout management information with a patient using a tablet.

Digital Gout Management Boosts Self-Management Outcomes

Smart gout management improved self-care, serum uric acid control, and renal markers in suburban patients.